Excision Medical, Inc., a Malvern, PA-based medical device company addressing the need for lifetime management of aortic stenosis through leaflet modification technology, raised $2.5M in financing.
The round was led by the internal team, with addition of Drs. James McCabe, MD (UW Medicine, Seattle, WA) and Adam Greenbaum, MD (Emory, Atlanta, GA) as Scientific Advisory Board members.
The company intends to use the funds to advance its catheter systems.
Excision is advancing The Excision Medical Leaflet Excision System, which is designed to allow physicians to target and excise one or more aortic valve leaflets while also considering the hemodynamic needs of patients.
The company was founded in 2020 by Greg Walters, former CEO of Essential Medical, Inc. (Teleflex, Inc.), Dr. Gary Roubin, MD, PhD, a coronary and carotid stenting pioneer, Dr. David Wood, MD, Head of Cardiology and Director of the Centre for Cardiovascular Innovation in Vancouver, British Columbia and Dr. Janarthanan Sathananthan, MD, MPH, Director of the Centre for Heart Valve Innovation Bench Testing Laboratory.
FinSMEs
15/09/2022